Navigation Links
NOVT Corporation's Board of Directors Terminates Shareholder Rights Plan
Date:10/8/2007

LOS GATOS, Calif., Oct. 8 /PRNewswire-FirstCall/ -- NOVT Corporation (Pink Sheets: NOVT.PK) ("the Company") today announced that its Board of Directors voted to terminate the Company's current shareholder rights plan. The Board of Directors determined the plan was no longer necessary due to the Company's reincorporation in Delaware and adoption of a new charter, which contains a provision protecting the Company's Net Operating Loss carryforwards. This new charter provision restricts the transfer of stock to a transferee (or a group in which the transferee is a member) if the transfer would either (i) increase the transferee's beneficial ownership of the Company to 4.75 percent or above or (ii) increase the transferee's beneficial ownership of the Company from 4.75 percent or above to a greater ownership interest percentage.

The rights plan will be terminated by changing its 2009 expiration date to October 29, 2007, while the Board retains the right to adopt a new plan at a future date in the event of changed circumstances.


'/>"/>
SOURCE NOVT Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Study casts doubt on keyboard ills
2. Who Board To Discuss Asian Tsunami Related Health Issues
3. Abdominal Crunches Not The Best Option For Wash Board Abs.
4. Computer Keyboards In Hospitals Could Spread Infection To Patients
5. Flu, Boarded A Ship?
6. Skateboarding to health
7. Shangai Citizens to Monitor Billboards
8. Budhia Is Fine, Government-constituted Medical Board Reports False
9. Pharmacy Board Says Pharmacists Have Right To Refuse Morning-After Pill
10. 115 people on board a cruise liner taken ill due to suspected Norovirus
11. Health Board and Doctors’ Association clash on working hours issu
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults 2Excess body weight causes over 124 000 new cancers a year in Europe 58238 1Excess body weight causes over 124 000 new cancers a year in Europe 58238 2Excess body weight causes over 124 000 new cancers a year in Europe 58238 3Deblistering Device Keeps Production Ahead Of Pack 14247 1Deblistering Device Keeps Production Ahead Of Pack 14247 2Deblistering Device Keeps Production Ahead Of Pack 14247 3Procedures Consult Internal Medicine Applications Now Available on App Store 58233 1Procedures Consult Internal Medicine Applications Now Available on App Store 58233 2Procedures Consult Internal Medicine Applications Now Available on App Store 58233 3